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Appraisal

Appraisal of Clinical Practice Guideline: Shoulder Pain and Mobility Deﬁcits:
Adhesive Capsulitis
Date of latest update: 2017. Date of next update: Not speciﬁed. Patient group: Patients with
shoulder pain and mobility deﬁcits (adhesive capsulitis). Intended audience: Patients with
adhesive capsulitis, orthopaedic physiotherapy clinicians, academic instructors, clinical instructors, students, interns and fellows. Original version: A detailed version was published in
the Journal of Orthopaedic & Sports Physical Therapy in 2013.1 Additional version: These
guidelines were reviewed by the Orthopaedic Section, American Physical Therapy
Association (APTA) in 2017. Both versions are available from the Academy of Orthopaedic
Physical Therapy (www.orthopt.org). Expert working group: The panel included experts
on developing clinical practice guidelines for musculoskeletal conditions of the shoulder
that are commonly treated by physiotherapists. Those experts were appointed by the
Orthopaedic section, APTA. Consultation with: Additional experts were invited to provide
consultation to the work group from other areas, including: orthopaedic physiotherapy
clinical practice and education; sports physiotherapy clinical practice and education;
orthopaedic surgeons; epidemiologists; claims review; coding and rheumatology. Funded
by: Not mentioned. Approved by: The Orthopaedic Section of APTA reviewed and
approved these guidelines for publication. Location: The guidelines and additional
documents are available at: https://www.orthopt.org/content/practice/clinical-practiceguidelines. Description and key recommendations: This clinical practice guideline was
presented as a Journal of Orthopaedic & Sports Physical Therapy special communication.
The recommendations are based on a systematic search of MEDLINE, CINAHL and the
Cochrane Database of Systematic Reviews. The main aim of the review was to create
evidence-based practice guidelines for orthopaedic physiotherapy management of patients with adhesive capsulitis, as described by the International Classiﬁcation of Functioning,
Disability and Health. Findings from the review were synthesised into 14 recommendations:
ﬁve pertained to impairment/function-based diagnosis, three to examination and six
to interventions. Each clinical research article was graded according to criteria described by
the Centre for Evidence-Based Medicine, Oxford, UK for diagnostic, prospective and
therapeutic studies (I. high-quality to V. expert opinion), and each recommendation
was assigned a level of conﬁdence (A. strong evidence to F. expert opinion). Of interest
to physiotherapists, the strongest recommendations (A) were for the use of validated

patient-reported functional outcome measures for examination, and for the use of
intra-articular corticosteroid injections combined with shoulder mobility and
stretching exercises to provide short-term (4 to 6 weeks) pain relief and improved
function. Moderate evidence (B) was available for the clinical course (staged progression of pain and mobility deﬁcits), patient education and stretching exercises. Female
patients aged 40 to 65 years and patients with diabetes and thyroid disease are at risk
for developing adhesive capsulitis (C-weak evidence). Weak evidence was also available for the use of modalities (shortwave diathermy, ultrasound, electrical stimulation)
combined with mobility and stretching exercises, and joint mobilisation to reduce pain
and increase motion. Transitional manipulation can be used if conservative interventions fail. The loss of passive motion in multiple planes, especially external
rotation, measuring pain, and active and passive range of motion can be used to guide
treatment planning. However, these measures were based on theoretical/foundational
(E) evidence. Lastly, expert opinion was available to conﬁrm diagnosis and for the use of
activity limitation and participation measures to assess shoulder improvement over
the episode of care.
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Appraisal of Clinical Practice Guideline: CRISM National Guideline for the Clinical
Management of Opioid Use Disorder
Date of latest update: 2018. Date of next update: 2021, within 1 year. Patient group: The
general patient population with opioid use disorder, which is deﬁned as a chronic relapsing illness that, although associated with elevated rates of morbidity and mortality,
has the potential to be in sustained remission with appropriate treatment. Intended
audience: Physicians and allied healthcare providers, nurse practitioners, pharmacists,
medical educators, or clinical care case managers with or without specialised experience
in addiction treatment. Additionally, this guideline may serve as a resource for policymakers and healthcare administrators at provincial and national levels for developing
evidence-based strategies and programs to address the current gaps in addiction care,
addiction medicine training and treatment access policies. Additional versions: Not
indicated. Expert working group: The pan-Canadian review committee consisted of 43
individuals, including primary care physicians, addiction medicine physicians, other
specialists, nurse practitioners, registered nurses, social workers, pharmacists, program
managers, program administrators, and policymakers. Funded by: The Canadian Institutes of Health Research (CIHR) funded The Canadian Research Initiative in Substance
Misuse (CRISM) network without pharmaceutical industry support. Consultation with:
External review to two international experts and two national stakeholder groups, the
Canadian Association of People Who Use Drugs (CAPUD) and moms united and mandated
to saving the lives of drug users (mumsDU). Approved by: The Canadian Research
Initiative in Substance Misuse (CRISM). Location: The guidelines and additional documents are available at http://www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.170958/-/DC1.
Description and key recommendations: The current guideline provides a 131-page

document with recommendations for promoting the evidence-based management of
opioid use disorder across addiction care in Canada. This guideline was then developed
under the Grading of Recommendations Assessment, Development, and Evaluation
(GRADE) framework. The full guidelines consist of development methods, a comprehensive review of evidence from both clinical and contextual perspectives, and
recommendations. The authors outline the full scope of opioid use disorder treatment
and suggest the endorsement of opioid agonist treatment with buprenorphine/naloxone
as ﬁrst-line management. This guideline strongly disagrees with withdrawal management without plans for transition to long-term evidence-based addiction treatment
(opioid agonist treatment). For physiotherapists, this guideline will help to improve
clinical patient outcomes such as pain and function. Meanwhile, it can enhance the
communication between healthcare professions and patients for behaviour change,
including opioid use disorder, overdose, or those experiencing other adverse events
related to these drugs.
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